Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
67 /100
HIGH RISK
Score updated Oct 13, 2026

BCTX — BriaCell Therapeutics Corp. Dilution Risk Tracker

Track BCTX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track BCTX — Get alerts when the score changes →

As of October 13, 2026, BriaCell Therapeutics Corp. (BCTX) has a DilutionWatch DilutionScore of 67/100, rated HIGH dilution risk. BriaCell Therapeutics Corp. has a market capitalization of $33.67M, 8.70M shares outstanding, 16 institutional holders tracked. Stored dilution-related fields include shelf registration capacity of $25.00M.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
90
💰 Cash Runway
65
📊 Float Risk
35
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

⛅
Watch
Minor dilution signals detected
model est. 20%
💰 Capital Raise model 35%
• Under 12 months cash (11mo)
• Active shelf registration ($25M, 74% of market cap)
📉 Score Deterioration model 10%
• Score in HIGH risk zone (67/100)
🔔 Track BCTX — Get forecast alerts →

Market Data

Market Cap$33.67M
Shares Outstanding8.70M
Float6.41M
Cash$22.80M
DebtN/A
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore67/100DilutionWatch score record
Shares Outstanding8.70MVerified float table or market cache
Public Float6.41MVerified float table or market cache
Market Cap$33.67MMarket data cache
Cash Runway10.6 monthsDilutionWatch score inputs
Shelf Capacity$25.00MSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 6.

Recent SEC source mix: 8-K 2, EFFECT 1, S-1 1, XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

16 institutional holders · 390.4K shares
#1 Cable Car Capital, LP 216.8K shares
#2 SABBY MANAGEMENT, LLC 73.9K shares
#3 IRIDIAN ASSET MANAGEMENT LLC/CT 65.0K shares
+ 13 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest779.1K
Days to Cover3.9
% of Float12.2%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2025-10-16
xbrl XBRL CONVERTIBLE 2022-10-28
8-K 8K EVENT 2026-02-20
8-K 8K EVENT 2026-01-15
EFFECT EFFECT 2026-01-13
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual BCTX Dilution Snapshot

BriaCell Therapeutics Corp. (BCTX) has a DilutionScore of 67/100, rated High dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

BCTX's DilutionScore is currently 67/100 (High risk), with 3 score changes tracked over 89 days. The score improved from 66/100 (High risk).

Period Score Risk Level Duration
Sep 17 – Oct 13, 202667/100HIGH27 days
Aug 22 – Sep 16, 202666/100HIGH26 days
Aug 14 – Aug 21, 202663/100HIGH7 days
Jul 16 – Aug 13, 202666/100HIGH29 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Track BCTX Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment BCTX files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking BCTX — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for BCTX
BCTX FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.